T4	Treatment 109 133	cyclophosphamide therapy
T5	Effect 4 52;79 95	development of erythroid leukemia plus carcinoma mutagenic change
T6	Subject 62 69	two men
T7	Population 62 65	two
T8	Gender 66 69	men
T10	Drug 109 125	cyclophosphamide
T3	Adverse_event 70 78	suggests
E1	Adverse_event:T3